Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Colonic Neoplasms × Panitumumab × Clear all

Phase

Status

Completed 17 Active not recruiting 3 Unknown 2 Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7 Esophageal Neoplasms 4 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Ovarian Neoplasms 1 Oesophago-gastric Cancer 1 KRAS and NRAS Wild-type Colorectal Cancer 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Cone Dystrophy 3 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Advanced Colorectal Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 23 Irinotecan 23 Fluorouracil 23 Leucovorin 21 Bevacizumab 21 Capecitabine 17 Cetuximab 13 Radiotherapy 5 Immunohistochemistry 4 Folfox protocol 4 Colonoscopy 4 Mitomycin 3 Gene Expression Profiling 3 Doxorubicin 3 Cisplatin 3 Cholecalciferol 3 Aspirin 3 Amplified Fragment Length Polymorphism Analysis 3 ixabepilone 2 cediranib 2 adagrasib 2 Tea 2 Surveys and Questionnaires 2 Sulindac 2 Stents 2 Reverse Transcriptase Polymerase Chain Reaction 2 Receptor Protein-Tyrosine Kinases 2 Radiofrequency Ablation 2 Radiation 2 Polymerase Chain Reaction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02015923 2021-03-16

CCRe-IV

Hospital Universitari de Bellvitge

Phase 4 Terminated

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡